Invention Grant
- Patent Title: Crystalline forms of hydroxynorketamine
-
Application No.: US16635406Application Date: 2018-07-31
-
Publication No.: US11377416B2Publication Date: 2022-07-05
- Inventor: David Pearson , Lorraine Sharp , Alan Armstrong , Richard Myerson , Jonathan Hull , Paul Blaney , Peter Rands , Marie Layzell , Zelah Joel
- Applicant: SMALL PHARMA LTD
- Applicant Address: GB London
- Assignee: SMALL PHARMA LTD
- Current Assignee: SMALL PHARMA LTD
- Current Assignee Address: GB London
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB1712304 20170731,GB1715010 20170918,GB1715500 20170925
- International Application: PCT/GB2018/052193 WO 20180731
- International Announcement: WO2019/025792 WO 20190207
- Main IPC: C07C225/20
- IPC: C07C225/20 ; A61K9/20 ; A61K9/48
Abstract:
The present invention provides novel, stable, processable and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamine or 2S,6S-hydroxynorketamine with high aqueous solubility.
Public/Granted literature
- US20200157040A1 CRYSTALLINE FORMS OF HYDROXYNORKETAMINE Public/Granted day:2020-05-21
Information query
